KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Return on Assets (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Return on Assets for 14 consecutive years, with 0.03% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets fell 8.0% to 0.03% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.03%, a 8.0% decrease, with the full-year FY2025 number at 0.03%, down 8.0% from a year prior.
  • Return on Assets was 0.03% for Q4 2025 at Supernus Pharmaceuticals, down from 0.01% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.07% in Q1 2021 to a low of 0.03% in Q4 2025.
  • A 5-year average of 0.03% and a median of 0.03% in 2021 define the central range for Return on Assets.
  • Biggest YoY gain for Return on Assets was 6bps in 2025; the steepest drop was -8bps in 2025.
  • Supernus Pharmaceuticals' Return on Assets stood at 0.03% in 2021, then rose by 9bps to 0.04% in 2022, then tumbled by -97bps to 0.0% in 2023, then skyrocketed by 5356bps to 0.05% in 2024, then tumbled by -149bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Return on Assets are 0.03% (Q4 2025), 0.01% (Q3 2025), and 0.05% (Q2 2025).